Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor.

Kolenda T, Rutkowski P, Michalak M, Kozak K, Guglas K, Ryś M, Galus Ł, Woźniak S, Ługowska I, Gos A, Teresiak A, Mackiewicz A, Lamperska K, Mackiewicz J.

Oncotarget. 2019 Jun 11;10(39):3879-3893. doi: 10.18632/oncotarget.26989. eCollection 2019 Jun 11.

2.

Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.

Kolenda T, Guglas K, Kopczyńska M, Teresiak A, Bliźniak R, Mackiewicz A, Lamperska K, Mackiewicz J.

Cells. 2019 Apr 21;8(4). pii: E366. doi: 10.3390/cells8040366.

3.

EGOT lncRNA in head and neck squamous cell carcinomas.

Kolenda T, Kopczyńska M, Guglas K, Teresiak A, Bliźniak R, Łasińska I, Mackiewicz J, Lamperska K.

Pol J Pathol. 2018;69(4):356-365. doi: 10.5114/pjp.2018.81695.

4.

Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome.

Kolenda T, Guglas K, Teresiak A, Bliźniak R, Lamperska K.

J Biomed Sci. 2019 Feb 13;26(1):17. doi: 10.1186/s12929-019-0511-3.

5.

lncRNA Expression after Irradiation and Chemoexposure of HNSCC Cell Lines.

Guglas K, Kolenda T, Teresiak A, Kopczyńska M, Łasińska I, Mackiewicz J, Mackiewicz A, Lamperska K.

Noncoding RNA. 2018 Nov 14;4(4). pii: E33. doi: 10.3390/ncrna4040033.

6.

lncRNA in HNSCC: challenges and potential.

Guglas K, Bogaczyńska M, Kolenda T, Ryś M, Teresiak A, Bliźniak R, Łasińska I, Mackiewicz J, Lamperska K.

Contemp Oncol (Pozn). 2017;21(4):259-266. doi: 10.5114/wo.2017.72382. Epub 2017 Dec 30. Review.

7.

Biological role of long non-coding RNA in head and neck cancers.

Kolenda T, Guglas K, Ryś M, Bogaczyńska M, Teresiak A, Bliźniak R, Łasińska I, Mackiewicz J, Lamperska KM.

Rep Pract Oncol Radiother. 2017 Sep-Oct;22(5):378-388. doi: 10.1016/j.rpor.2017.07.001. Epub 2017 Aug 1. Review.

Supplemental Content

Loading ...
Support Center